Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million
On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics (NASDAQ:APGE), an estimated $3.87 ...
Tuesday, March 31, 2026
Tag: Apogee
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.